The next meeting is on October 13th 2022


SUP fall meeting 2022


Dear all,


After a way too long break, we are happy to announce that the SUP network will have its next meeting on October 13th, this time in Uppsala. The theme will be “PBPK and mechanistic PK models”, and we’re quite excited about having a diverse program with both implementation and methodology. As always, we expect to have a lot of social and scientific discussions during our breaks, but would also like to invite you to stay on afterwards for something to eat and drink. The SUP meeting itself is as always free for all participants, while you would need to pay for post meeting drinks and food.


Venue is still being negotiated, but most likely will be close to Uppsala central station for the convenience of out-of-towners.



Please find the attached schedule for the afternoon below. Also feel free to share the invite with anyone in your network who might be interested, the more the merrier.



If you could let us know if you would like to participate in the meeting by October 7th, that would be great, and also let us know whether you’re interested in staying for the social event.


Sign up (by October 7th) using the left button above


See you in Uppsala,


/The organizing committee
(Johan Wallin, David Khan, Bengt Hamrén, Maria Kjellsson, Daniel Röshammar, Adam Darwich, Lars Lindbom and Mats Karlsson)





Schedule



Session 1, 13:00-14:30

Vijender Panduga, AstraZeneca
“Utilization of PBPK-modelling based approach and the organizational set up in support of AstraZeneca’s clinical pharmacology strategy”
Urban Fagerholm, Prosilico
“In silico prediction of human clinical pharmacokinetics of drugs with multi-mechanic and complex pharmacokinetic characteristics.”


Luna Prieto Garcia, AstraZeneca
“Does the Choice of Applied Physiologically-Based Pharmacokinetics Platform Matter? A Case Study on Simvastatin Disposition and Drug-Drug Interaction”

 

Break #1  14:30-15:15

 

Session 2, 15:15-16:15


Christer Tannergren, AstraZeneca

” Introduction to Physiologically Based Biopharmaceutics Modeling (PBBM) – Model Development, Applications & Benefits”

 

Erik Sjögren, Pharmetheus

“Predicting drug absorption and immunogenicity after subcutaneous administration of therapeutic proteins.”

 

Break #2  16:15-17:00

 
Session 3  17:00-18:00


Anders Thorsted, Uppsala Universitet

“Predicting the long-term effects of therapeutic inhibition of Oncostatin M on human hematopoiesis”

 

Linda Aulin, qPhametra

“Translational PK/PD modelling in the context of Flagellin Aerosol therapy as an Immunomodulatory adjunct to the antibiotic treatment of drug-Resistant bacterial pneumonia (FAIR)”

 

18:00 Mingle (Location to be announced)



Stockholm Uppsala Pharmacometrics (SUP)